References
- Hector RF, Zimmer BL, Pappagianis D. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother 1990; 34: 587–593.
- Nix DE, Swezey RR, Hector R, Galgiani JN. Pharmacokinetics of Nikkomycin Z after single rising oral doses. Antimicrob Agents Chemother 2009; 53: 2517–2521.
- Clemons KV, Capilla J, Stevens DA. Experimental animal models of coccidioidomycosis. In: Clemons KV, Laniado–Laborin R, Stevens DA (eds). Sixth International Symposium on Coccidioidomycosis, Stanford University, Aug. 23–26, 2006. Boston, MA: Annals NY Acad Science 2007; 1111: 208–224.
- Shubitz LF, Dial SM, Perrill R, Casement R, Galgiani JN. Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun 2008; 76: 5553–5564.
- Johnson LR, Hergesell EJ, Davidson AP, Pappagianis D. Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995–2000). J Am Vet Med Assoc 2003; 222: 461–466.
- Greene RT. Coccidioidomycosis. In: Greene CE (ed). Infectious Diseases in the Dog and Cat. Philadelphia, PA: W.B. Saunders Company, 1998: 391–398.
- Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis 2007; 45: 562–568.
- Shubitz LF, Trinh H, Perrill R, et al. Nikkomycin Z for treatment of murine pulmonary coccidioidomycosis. Antimicrobial Agents Chemother (submitted).